| Sign In to gain access to subscriptions and/or personal tools. |
Foscarnet-Induced Electrolyte Abnormalities in a Bone Marrow Transplant Patient Receiving Parenteral NutritionDepartment of General Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of Pharmacy, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of General Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio Cytomegalovirus (CMV) is a serious complication of immunosuppressed patients receiving bone marrow transplantation. Foscarnet, a pyrophosphate analog, has been used in the treatment of CMV infections. Renal impairment and electrolyte abnormalities are potential adverse reactions associated with the use of foscarnet. We report a case of significant electrolyte changes after initiation of foscarnet in a bone marrow transplant patient receiving parenteral nutrition. (Journal of Parenteral and Enteral Nutrition 24:170-173, 2000)
Journal of Parenteral and Enteral Nutrition, Vol. 24, No. 3,
170-173 (2000) This article has been cited by other articles:
|
|
|||||||||||||||

